Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Interferon.

K F Trofatter1

  • 1Department of Obstetrics and Gynecology, Duke University Medical Center, Durham, North Carolina.

Obstetrics and Gynecology Clinics of North America
|June 1, 1987
PubMed
Summary

Interferons show promise for treating difficult cases of condylomata acuminata. Combining interferons with standard treatments offers hope for managing this challenging viral infection.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Increased frequency of dosing of imiquimod 5% cream in the treatment of external genital warts in women.

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics·2002
Same author

Imiqimod in clinical practice.

European journal of dermatology : EJD·1999
Same author

Imiquimod, a patient-applied immune-response modifier for treatment of external genital warts.

Antimicrobial agents and chemotherapy·1998
Same author

Diagnosis of human papillomavirus genital tract infection.

The American journal of medicine·1997
Same author

D-dimer test for early detection of HELLP syndrome.

Southern medical journal·1995
Same author

Effect of preinduction cervical softening with dinoprostone gel on outcome of oxytocin-induced labor.

Clinical therapeutics·1993

Area of Science:

  • Immunology
  • Dermatology
  • Virology

Background:

  • Recalcitrant condylomata acuminata presents a significant clinical challenge.
  • Conventional treatments may be insufficient for severe or persistent cases.
  • Interferons are a class of cytokines with antiviral and immunomodulatory properties.

Purpose of the Study:

  • To evaluate the efficacy of interferons in managing recalcitrant condylomata acuminata.
  • To explore the role of interferons, alone and in combination with other therapies.

Main Methods:

  • Review of existing literature on interferon therapy for condylomata acuminata.
  • Analysis of established dosage schedules balancing efficacy and toxicity.
  • Assessment of combination therapy approaches.

Main Results:

  • Interferons demonstrate utility in managing difficult condylomata acuminata cases.
  • Optimized dosage schedules have been developed to mitigate systemic toxicity.
  • Interferons are not universally effective as monotherapy.

Conclusions:

  • Interferon therapy, particularly in combination with conventional modalities, offers a promising strategy for controlling condylomata acuminata.
  • This approach provides hope for patients with this frustrating and potentially serious viral infection.

Related Experiment Videos